Pfizer CEO Albert Bourla (L) and Moderna CEO Stéphane Bancel (Matthew Busch/Bloomberg via Getty Images; Nancy Lane/The Boston Herald via AP Images, Pool)

Pfiz­er's Bourla and Mod­er­na's Ban­cel saw com­pen­sa­tion bumps in 2022

More Big Phar­mas and hot­ly-watched biotechs have dis­closed the to­tal com­pen­sa­tion fig­ures for their ex­ec­u­tives, high­light­ing the pay pack­ages of Covid-19 be­he­moths, in­sulin mak­ers and rare dis­ease drug de­vel­op­ers.

Pfiz­er CEO Al­bert Bourla brought in $33.01 mil­lion, Mod­er­na’s Stéphane Ban­cel racked up $19.36 mil­lion, Eli Lil­ly’s Dave Ricks lined up $21.398 mil­lion, Sanofi’s Paul Hud­son snagged €10.718 mil­lion (about $11.38 mil­lion), John­son & John­son’s Joaquin Du­a­to made $13.09 mil­lion, and the leader of Hori­zon Ther­a­peu­tics, Tim Wal­bert, nabbed $20.1 mil­lion last year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.